a. Switched to prasugrel in 1 patient, warfarin in 1 patient, and aspirin/ extended release dipyridamole in 1 patient
b. Warfarin was added to 2 patients, and aspirin was added to 1 patient
Figure 1: Impact on clinical outcomes after a positive P2Y12 test in nonsurgical patients